Intech Investment Management LLC increased its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) by 42.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,813 shares of the company’s stock after acquiring an additional 5,566 shares during the quarter. Intech Investment Management LLC’s holdings in Aveanna Healthcare were worth $86,000 as of its most recent filing with the SEC.
A number of other large investors have also recently added to or reduced their stakes in AVAH. First Eagle Investment Management LLC bought a new stake in shares of Aveanna Healthcare in the 4th quarter valued at approximately $1,992,000. Jacobs Levy Equity Management Inc. boosted its holdings in Aveanna Healthcare by 297.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock worth $1,848,000 after purchasing an additional 265,969 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Aveanna Healthcare during the third quarter valued at $817,000. Swiss National Bank acquired a new stake in shares of Aveanna Healthcare during the fourth quarter worth $434,000. Finally, Jane Street Group LLC lifted its position in shares of Aveanna Healthcare by 127.4% in the 3rd quarter. Jane Street Group LLC now owns 118,803 shares of the company’s stock worth $618,000 after buying an additional 66,561 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
AVAH has been the topic of several research reports. Truist Financial dropped their price objective on shares of Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating on the stock in a research note on Monday, January 6th. UBS Group increased their price target on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a research report on Friday, March 14th.
Aveanna Healthcare Stock Down 2.7 %
Shares of NASDAQ:AVAH opened at $5.37 on Friday. The company’s 50-day moving average price is $4.73 and its 200 day moving average price is $4.96. The company has a market cap of $1.05 billion, a PE ratio of -15.79 and a beta of 2.25. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.11 and a fifty-two week high of $6.19.
Insider Buying and Selling at Aveanna Healthcare
In other news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64. Following the transaction, the insider now directly owns 1,453,948 shares of the company’s stock, valued at approximately $8,011,253.48. This trade represents a 4.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 7.80% of the stock is owned by company insiders.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
- Five stocks we like better than Aveanna Healthcare
- 3 Warren Buffett Stocks to Buy Now
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to Short a Stock in 5 Easy Steps
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Why Invest in 5G? How to Invest in 5G Stocks
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report).
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.